FDA panel scrutinizes safety of anti-anemia drugs. Journal of the National Cancer Institute. [J Natl Cancer Inst] Journal article

Title	FDA panel scrutinizes safety of anti-anemia drugs.
Author(s)	Randal J
Source	J Natl Cancer Inst 2004 Jul 21; 96(14):1061.
MeSH	Advertising Anemia Erythropoietin Erythropoietin, Recombinant Hematinics Humans Multicenter Studies Neoplasms Prognosis Randomized Controlled Trials United States United States Food and Drug Administration
Language	eng
Pub Type(s)	News
PubMed ID	15265966

Advertise on this site.